• Dr. Yan Sanders received her medical degree from Hunan Medical University, China. Then she went to graduate school at University of Arkansas for Medical Sciences. She completed a postdoctoral research fellowship at the National Center for Toxicological Research before she joined UAB at pediatric pulmonary, late she joined the faculty of medicine at the rank of Assistant Professor in 2011.
  • Selected Publications

    Academic Article

    Year Title Altmetric
    2019 Inhibition of Glutaminase 1 Attenuates Experimental Pulmonary Fibrosis. 2019
    2019 Betting on novel treatments for asthma: Bromodomain 4 inhibitors 2019
    2019 Glutaminolysis epigenetically regulates antiapoptotic gene expression in idiopathic pulmonary fibrosis fibroblasts 2019
    2019 HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis. 2019
    2018 Glutaminolysis is required for transforming growth factor-β1-induced myofibroblast differentiation and activation 2018
    2017 DNA methylation regulated gene expression in organ fibrosis 2017
    2017 Epigenetic regulation of caveolin-1 gene expression in lung fibroblasts 2017
    2016 Novel mechanisms for the antifibrotic action of nintedanib 2016
    2015 SMAD-independent down-regulation of caveolin-1 by TGF-β: Effects on proliferation and survival of myofibroblasts 2015
    2015 Epigenetic mechanisms regulate NADPH oxidase-4 expression in cellular senescence 2015
    2014 TGF-beta downregulation of distinct chloride channels in cystic fibrosis-affected epithelia 2014
    2014 Histone deacetylase inhibition promotes fibroblast apoptosis and ameliorates pulmonary fibrosis in mice 2014
    2014 Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance 2014
    2013 Histone deacetylase inhibition downregulates collagen 3A1 in fibrotic lung fibroblasts 2013
    2013 Histone modifications in senescence-associated resistance to apoptosis by oxidative stress 2013
    2012 Altered DNA methylation profile in idiopathic pulmonary fibrosis 2012
    2012 Participation of miR-200 in pulmonary fibrosis 2012
    2011 Absence of Thy-1 results in TGF-Β induced MMP-9 expression and confers a profibrotic phenotype to human lung fibroblasts 2011
    2011 Epigenetic regulation of Thy-1 by histone deacetylase inhibitor in rat lung fibroblasts 2011
    2008 Thy-1 promoter hypermethylation: A novel epigenetic pathogenic mechanism in pulmonary fibrosis 2008
    2007 Enhanced myofibroblastic differentiation and survival in thy-1(-) lung fibroblasts 2007
    2002 Increased expression of heterogeneous nuclear ribonucleoprotein A2/B1 (hnRNP) in pancreatic tissue from smokers and pancreatic tumor cells. 2002
    2001 Specific site methylation in the 5'-flanking region of CYP1A2 interindividual differences in human livers. 2001


    Year Title Altmetric
    2014 Signaling Networks Controlling Cellular Senescence.  67-83. 2014

    Research Overview

  • Dr. Sanders' main research interests are on the epigenetics aspects of lung injury, repair, aging, and aging related diseases. The main focuses of this research are the roles of histone modifications and DNA methylation in aging related diseases, such as pulmonary fibrosis. Ongoing projects include exploring epigenetic alterations in idiopathic pulmonary fibrosis (IPF), examining the effects of histone modifiers on fibrotic lung fibroblasts, determining the epigenetic mechanisms of cellular senescence, aging and age-related chronic diseases, specifically histone modifications and DNA methylation.
  • Full Name

  • Yan Sanders